ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 278

$595K Total Retail Price of All Prescriptions

Rank: 79 out of 278

505 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,489 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 467 365 1 4
HYDROCODONE-ACETAMINOPHEN 399 258 S3 2 1
AMLODIPINE BESYLATE 386 284 3 7
OMEPRAZOLE 382 317 4 3
LISINOPRIL 336 276 5 5
LEVOTHYROXINE SODIUM 330 254 6 2
HYDROCHLOROTHIAZIDE 252 179 7 15
FUROSEMIDE 236 214 8 6
FLUTICASONE PROPIONATE 235 194 9 44
SERTRALINE HCL 221 168 10 25
METFORMIN HCL 214 170 11 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 214 175 11 31
METOPROLOL SUCCINATE 193 160 13 10
GABAPENTIN 165 103 14 12
NEXIUM 150 89 15 14
MELOXICAM 149 113 16 37
ZOLPIDEM TARTRATE 143 128 17 26
TRAMADOL HCL 134 99 18 22
PRAVASTATIN SODIUM 133 123 19 16
LOSARTAN-HYDROCHLOROTHIAZIDE 133 116 19 54
WARFARIN SODIUM 128 107 21 11
METOPROLOL TARTRATE 127 98 22 9
ATORVASTATIN CALCIUM 125 103 23 13
CRESTOR 122 112 24 19
LOSARTAN POTASSIUM 117 90 25 24
PANTOPRAZOLE SODIUM 114 76 26 36
TAMSULOSIN HCL 112 97 27 32
CITALOPRAM HBR 109 70 28 21
AMITRIPTYLINE HCL 91 69 R 29 73
CARVEDILOL 88 63 30 23
AZITHROMYCIN 86 69 31 39
PAROXETINE HCL 85 60 32 57
ATENOLOL 81 75 33 18
RANITIDINE HCL 79 48 34 27
NAPROXEN 78 65 35 115
POTASSIUM CHLORIDE 77 60 36 17
PLAVIX 77 73 36 30
CLOPIDOGREL 73 69 38 20
GLIPIZIDE ER 70 63 39 136
DONEPEZIL HCL 69 69 40 29
SPIRIVA 63 50 41 49
ADVAIR DISKUS 60 57 42 45
PREDNISONE 60 49 42 35
PROAIR HFA 59 36 44 34
ALLOPURINOL 57 56 45 38
GLIPIZIDE 57 52 45 55
PRADAXA 55 55 47 166
SYNTHROID 55 42 47 46
DIGOXIN 53 49 49 40
NAMENDA 52 52 50 48
ISOSORBIDE MONONITRATE ER 51 25 51 33
IBUPROFEN 50 37 52 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.